Twist's Unconventional Approach, Adding Value One Rung At A Time

Building a narrow set of products and services that provide reliable and consistent revenue is a perfectly sound business strategy and one that sustains many biotech companies. But for the hungrier, like Twist Bioscience, Inc., a strategy of ongoing disruption and evolution has been more appealing and indeed is generating significant growth. Emily Leproust, Twist’s CEO, spoke with In Vivo about what it means to follow a value-added business strategy.

An Unconventional Value-Added Business Strategy at Twist Has Paid Off
Twist Bioscience's Unconventional Value-Added Business Strategy Is Paying Off • Source: Shutterstock

More from Business Strategy

More from In Vivo